MX9708853A - Factor trofico para el musculo. - Google Patents
Factor trofico para el musculo.Info
- Publication number
- MX9708853A MX9708853A MX9708853A MX9708853A MX9708853A MX 9708853 A MX9708853 A MX 9708853A MX 9708853 A MX9708853 A MX 9708853A MX 9708853 A MX9708853 A MX 9708853A MX 9708853 A MX9708853 A MX 9708853A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- muscle
- methods
- trophic factor
- intolerance
- Prior art date
Links
- 210000003205 muscle Anatomy 0.000 title 1
- 230000001228 trophic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 208000002705 Glucose Intolerance Diseases 0.000 abstract 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 102000003812 Interleukin-15 Human genes 0.000 abstract 1
- 108090000172 Interleukin-15 Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 208000020538 atrophic muscular disease Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000013372 meat Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 230000037257 muscle growth Effects 0.000 abstract 1
- 201000006938 muscular dystrophy Diseases 0.000 abstract 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 abstract 1
- 230000009291 secondary effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5443—IL-15
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se describen composiciones y métodos para estimular crecimiento o diferenciacion del musculo en un vertebrado. Dichas composiciones incluyen una cantidad trofica para el musculo de interleucina-15 y se pueden usar para tratar una variedad de condiciones que incluyen atrofia por falta de uso, desgaste, varios trastornos relacionados con la edad, efectos secundarios de diabetes, incluyendo intolerancia a la glucosa, así como distrofia muscular, rabdomiosarcoma y falla del corazon congestiva. Las composiciones y métodos de la invencion encuentran uso agrícola para tratar la eficiencia de produccion de carne y leche de animales de la granja.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08535733 | 1995-05-24 | ||
| US08/535,733 US5660824A (en) | 1995-05-24 | 1995-05-24 | Muscle trophic factor |
| PCT/US1996/006423 WO1996037223A1 (en) | 1995-05-24 | 1996-05-07 | Muscle trophic factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9708853A true MX9708853A (es) | 1998-03-31 |
| MXPA97008853A MXPA97008853A (es) | 1998-10-15 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| NZ307845A (en) | 1999-10-28 |
| EP0831902A4 (en) | 2002-04-17 |
| WO1996037223A1 (en) | 1996-11-28 |
| CA2221148C (en) | 2000-10-24 |
| AU705609B2 (en) | 1999-05-27 |
| JPH11505836A (ja) | 1999-05-25 |
| AU5730796A (en) | 1996-12-11 |
| EP0831902A1 (en) | 1998-04-01 |
| US5660824A (en) | 1997-08-26 |
| CA2221148A1 (en) | 1996-11-28 |
| NO975238L (no) | 1998-01-23 |
| NO975238D0 (no) | 1997-11-14 |
| KR19990014835A (ko) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2221148A1 (en) | Muscle trophic factor | |
| BG103429A (en) | Methods and compositions for neurone growth stimulation | |
| ATE277638T1 (de) | Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten. | |
| NO20042151L (no) | Sammensetning for a forbedre skjelettvekst og opprettholdelse av benhelse | |
| GEP20043303B (en) | Polycycloalkylpurines as Adenosine Receptor Antagonists | |
| AU1277688A (en) | Sustained release compositions for parenteral administration and their use | |
| NZ544801A (en) | Antiseptic compositions, methods and systems | |
| MXPA04004732A (es) | Composiciones y estuches que comprenden un compuesto definido de boro, metodos para prepararlas y uso y administracion de las mismas. | |
| PT2009025E (pt) | Método de inibição da actividade dos osteoclastos | |
| GEP20043267B (en) | Adenosine Receptor Antagonists, Methods of Making and Using the Same | |
| AU2284001A (en) | Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone | |
| DE69634404D1 (de) | Caroteinoid-nicotinamid-zink zusammensetzungen und verfahren zur behandlung unter verwendung derselben | |
| PL346143A1 (en) | Tan-1057 derivatives | |
| PL1667678T3 (pl) | Mieszanka paszowa dla zwierząt | |
| AP1563A (en) | Lactic acid bacteria for the treatment and /or prophylaxis of giardiasis. | |
| GR3002583T3 (en) | Process for stimulating the growth and the health of crops | |
| BG104958A (en) | Stable compositions comprising levosimendan and alginic acid | |
| EP1390388A4 (en) | ANTISENSE MODULATION OF INTERFERON GAMMA RECEPTOR 1 EXPRESSION | |
| WO1999016406A3 (en) | Therapeutic method | |
| MX9704704A (es) | Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su obtencion, medicamentos que contienen estos compuestos, y su utilizacion. | |
| ATE375162T1 (de) | Verwendung von zeolithen zur senkung der anteile von lactaten im menschlichen und tierischen organismus | |
| EP1103255A4 (en) | CULTIVATION AND FOOD PROCESS | |
| Kulkarni et al. | Biochemical alterations in muscles of Periplanata americana induced by sublethal administration of cypermethrin, carbaryl and monocrotophos | |
| NZ323207A (en) | Hemoregulatory compounds | |
| UA74406C2 (uk) | Полісахаридна сполука з імуностимулювальною активністю, спосіб її одержання, застосування та фармацевтичний препарат на її основі |